Versican expression in human cervical cancer

J. Kodama, Hasengaowa, T. Kusumoto, N. Seki, T. Matsuo, Keiichiro Nakamura, A. Hongo, Y. Hiramatsu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Versican expression may enhance tumour invasion and metastasis. However, the expressions of versican in cervical cancer have seldom been characterised. The aim of this study was to investigate versican expression in human cervical cancers. We immunohistochemically investigated the expression of versican protein in 174 cervical cancers and analysed the correlation with various clinicopathological features, including patient outcome. Stromal versican expression was significantly higher in patients with lymph node metastasis (p <0.0001). Epithelial versican expression was significantly higher in patients with non-squamous cell cercinoma (p = 0.0003), lymph-vascular space invasion (p = 0.046), lymph node metastasis (p = 0.009) and ovarian metastasis (p = 0.0001). Multivariate analysis showed that high epithelial versican expression was an independent prognostic factor for disease-free survival. Versican enrichment of the tumour tissue may be associated with progression in cervical cancer. Versican expression can serve as an indicator of poor prognosis in patients with cervical cancer.

Original languageEnglish
Pages (from-to)1460-1466
Number of pages7
JournalEuropean Journal of Cancer
Volume43
Issue number9
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Versicans
Uterine Cervical Neoplasms
Neoplasm Metastasis
Lymph Nodes
Lymph
Disease-Free Survival
Blood Vessels
Neoplasms
Multivariate Analysis

Keywords

  • Cervical cancer
  • Metastasis
  • Prognosis
  • Versican

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Kodama, J., Hasengaowa, Kusumoto, T., Seki, N., Matsuo, T., Nakamura, K., ... Hiramatsu, Y. (2007). Versican expression in human cervical cancer. European Journal of Cancer, 43(9), 1460-1466. https://doi.org/10.1016/j.ejca.2007.02.007

Versican expression in human cervical cancer. / Kodama, J.; Hasengaowa; Kusumoto, T.; Seki, N.; Matsuo, T.; Nakamura, Keiichiro; Hongo, A.; Hiramatsu, Y.

In: European Journal of Cancer, Vol. 43, No. 9, 06.2007, p. 1460-1466.

Research output: Contribution to journalArticle

Kodama, J, Hasengaowa, Kusumoto, T, Seki, N, Matsuo, T, Nakamura, K, Hongo, A & Hiramatsu, Y 2007, 'Versican expression in human cervical cancer', European Journal of Cancer, vol. 43, no. 9, pp. 1460-1466. https://doi.org/10.1016/j.ejca.2007.02.007
Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Nakamura K et al. Versican expression in human cervical cancer. European Journal of Cancer. 2007 Jun;43(9):1460-1466. https://doi.org/10.1016/j.ejca.2007.02.007
Kodama, J. ; Hasengaowa ; Kusumoto, T. ; Seki, N. ; Matsuo, T. ; Nakamura, Keiichiro ; Hongo, A. ; Hiramatsu, Y. / Versican expression in human cervical cancer. In: European Journal of Cancer. 2007 ; Vol. 43, No. 9. pp. 1460-1466.
@article{5874d16544e74e8587a4bab82ab90282,
title = "Versican expression in human cervical cancer",
abstract = "Versican expression may enhance tumour invasion and metastasis. However, the expressions of versican in cervical cancer have seldom been characterised. The aim of this study was to investigate versican expression in human cervical cancers. We immunohistochemically investigated the expression of versican protein in 174 cervical cancers and analysed the correlation with various clinicopathological features, including patient outcome. Stromal versican expression was significantly higher in patients with lymph node metastasis (p <0.0001). Epithelial versican expression was significantly higher in patients with non-squamous cell cercinoma (p = 0.0003), lymph-vascular space invasion (p = 0.046), lymph node metastasis (p = 0.009) and ovarian metastasis (p = 0.0001). Multivariate analysis showed that high epithelial versican expression was an independent prognostic factor for disease-free survival. Versican enrichment of the tumour tissue may be associated with progression in cervical cancer. Versican expression can serve as an indicator of poor prognosis in patients with cervical cancer.",
keywords = "Cervical cancer, Metastasis, Prognosis, Versican",
author = "J. Kodama and Hasengaowa and T. Kusumoto and N. Seki and T. Matsuo and Keiichiro Nakamura and A. Hongo and Y. Hiramatsu",
year = "2007",
month = "6",
doi = "10.1016/j.ejca.2007.02.007",
language = "English",
volume = "43",
pages = "1460--1466",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Versican expression in human cervical cancer

AU - Kodama, J.

AU - Hasengaowa,

AU - Kusumoto, T.

AU - Seki, N.

AU - Matsuo, T.

AU - Nakamura, Keiichiro

AU - Hongo, A.

AU - Hiramatsu, Y.

PY - 2007/6

Y1 - 2007/6

N2 - Versican expression may enhance tumour invasion and metastasis. However, the expressions of versican in cervical cancer have seldom been characterised. The aim of this study was to investigate versican expression in human cervical cancers. We immunohistochemically investigated the expression of versican protein in 174 cervical cancers and analysed the correlation with various clinicopathological features, including patient outcome. Stromal versican expression was significantly higher in patients with lymph node metastasis (p <0.0001). Epithelial versican expression was significantly higher in patients with non-squamous cell cercinoma (p = 0.0003), lymph-vascular space invasion (p = 0.046), lymph node metastasis (p = 0.009) and ovarian metastasis (p = 0.0001). Multivariate analysis showed that high epithelial versican expression was an independent prognostic factor for disease-free survival. Versican enrichment of the tumour tissue may be associated with progression in cervical cancer. Versican expression can serve as an indicator of poor prognosis in patients with cervical cancer.

AB - Versican expression may enhance tumour invasion and metastasis. However, the expressions of versican in cervical cancer have seldom been characterised. The aim of this study was to investigate versican expression in human cervical cancers. We immunohistochemically investigated the expression of versican protein in 174 cervical cancers and analysed the correlation with various clinicopathological features, including patient outcome. Stromal versican expression was significantly higher in patients with lymph node metastasis (p <0.0001). Epithelial versican expression was significantly higher in patients with non-squamous cell cercinoma (p = 0.0003), lymph-vascular space invasion (p = 0.046), lymph node metastasis (p = 0.009) and ovarian metastasis (p = 0.0001). Multivariate analysis showed that high epithelial versican expression was an independent prognostic factor for disease-free survival. Versican enrichment of the tumour tissue may be associated with progression in cervical cancer. Versican expression can serve as an indicator of poor prognosis in patients with cervical cancer.

KW - Cervical cancer

KW - Metastasis

KW - Prognosis

KW - Versican

UR - http://www.scopus.com/inward/record.url?scp=34249885071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249885071&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2007.02.007

DO - 10.1016/j.ejca.2007.02.007

M3 - Article

C2 - 17446061

AN - SCOPUS:34249885071

VL - 43

SP - 1460

EP - 1466

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -